DNMT3A and acute myeloid leukemia: Early studies suggest that DNMT3A mutations are involved in hematological malignancies such as myelodysplastic syndrome (MDS), adult early T-cell precursor acute lymphoblastic leukemia (ETP-ALL), and AML [13–17].